Why do we have so few effective drugs for irritable bowel syndrome? A European perspective

Nat Clin Pract Gastroenterol Hepatol. 2005 Oct;2(10):436-7. doi: 10.1038/ncpgasthep0292.
No abstract available

MeSH terms

  • Drug Approval
  • Europe
  • Humans
  • Irritable Bowel Syndrome / drug therapy*
  • Irritable Bowel Syndrome / etiology
  • Irritable Bowel Syndrome / physiopathology